172 related articles for article (PubMed ID: 12766954)
1. Transurethral endoscopic treatment of upper urinary tract tumors using a holmium:YAG laser.
Matsuoka K; Lida S; Tomiyasu K; Inoue M; Noda S
Lasers Surg Med; 2003; 32(5):336-40. PubMed ID: 12766954
[TBL] [Abstract][Full Text] [Related]
2. Long-term results and management of ureteral transitional cell carcinoma using the holmium: YAG laser via rigid-ureteroscopy.
Yamada Y; Inoue Y; Nakamura K; Naruse K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Hara K; Kato Y; Watanabe M; Hayashida K; Suzuki Y; Kato H; Ajisaka R; Kyoku I; Noguchi H; Honda N
Oncol Rep; 2009 Feb; 21(2):345-9. PubMed ID: 19148506
[TBL] [Abstract][Full Text] [Related]
3. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma.
Keeley FX; Bibbo M; Bagley DH
J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience of ureteroscopic treatment for ureteral transitional cell carcinoma using the Holmium:YAG laser.
Yamada Y; Honda N; Nakamura K; Hibi H; Nanaura H; Nishikawa E; Kamijou A; Mitsui K; Taki T; Aoki S; Kokubo H; Fukatsu H
Oncol Rep; 2003; 10(4):821-5. PubMed ID: 12792729
[TBL] [Abstract][Full Text] [Related]
5. [Laser coagulation treatment of urothelial tumors of the upper urogenital tract with the Nd:-YAG laser].
Theodorakis J; Klammert R; Kriegmair M
Urologe A; 1994 Jul; 33(4):303-7. PubMed ID: 7941177
[TBL] [Abstract][Full Text] [Related]
6. Imperative indications for conservative management of upper tract transitional cell carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
[TBL] [Abstract][Full Text] [Related]
7. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
8. Transurethral endoscopic treatment of patients with upper tract urothelial carcinomas using neodymium-YAG and/or holmium-YAG laser ablation.
Tada Y; Yokomizo A; Koga H; Seki N; Kuroiwa K; Tatsugami K; Yamaguchi A; Naito S
BJU Int; 2010 Aug; 106(3):362-6. PubMed ID: 20201842
[TBL] [Abstract][Full Text] [Related]
9. [Ureteroscopy in the follow-up protocol for upper urinary tract urothelial tumors treated endoscopically].
Amón Sesmero JH; Estébanez Zarranz J; Conde Redondo C; Robles Samaniego A; Del Valle González N; Martínez-Sagarra Oceja JM
Arch Esp Urol; 2004 Apr; 57(3):303-10. PubMed ID: 15174509
[TBL] [Abstract][Full Text] [Related]
10. [Endoscopic management of urothelial tumours of the upper urinary tract].
Tomatis L; Neuzillet Y; Carcenac A; Nahon O; Lay F; Lechevallier E; Coulange C
Prog Urol; 2006 Apr; 16(2):151-4. PubMed ID: 16734236
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
Urology; 2008 Apr; 71(4):713-7. PubMed ID: 18267338
[TBL] [Abstract][Full Text] [Related]
12. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS
Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357
[TBL] [Abstract][Full Text] [Related]
13. [Percutaneous treatment of tumors of the upper urinary tract].
Nesa S; Cosyns JP; Saleh A; Wese FX; Opsomer RJ; Dardenne A; Lorge F; Van Cangh PJ
Acta Urol Belg; 1995 Mar; 63(1):43-51. PubMed ID: 7725992
[TBL] [Abstract][Full Text] [Related]
14. [Nephron-sparing endoscopic treatment using a Ho: YAG laser of three patients with upper urinary tract urothelial tumors].
Horiuchi K; Shimizu H; Tsuboi N; Uchikoba T; Miura T; Kimura G; Kondo Y; Nishimura T
J Nippon Med Sch; 2001 Jun; 68(3):275-8. PubMed ID: 11404777
[No Abstract] [Full Text] [Related]
15. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
16. Transurethral approach to the distal ureter in nephroureterectomy: transurethral extraction vs. "pluck" technique with long-term follow-up.
Ubrig B; Boenig M; Waldner M; Roth S
Eur Urol; 2004 Dec; 46(6):741-7. PubMed ID: 15548441
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic treatment of upper and lower urinary tract lesions using lasers.
Carson CC
Semin Urol; 1991 Aug; 9(3):185-91. PubMed ID: 1947521
[No Abstract] [Full Text] [Related]
18. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
Koda S; Mita K; Shigeta M; Usui T
Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
[TBL] [Abstract][Full Text] [Related]
20. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
